Available online on 15.06.2022 at http://jddtonline.info
Journal of Drug Delivery and Therapeutics
Open Access to Pharmaceutical and Medical Research
Copyright © 2022 The Author(s): This is an open-access article distributed under the terms of the CC BY-NC 4.0 which permits unrestricted use, distribution, and reproduction in any medium for non-commercial use provided the original author and source are credited
Open Access Full Text Article Research Article
New Smartphone based Colorimetric Method Development and validation for the Drugs containing Nitrogen, Sulphur and Phosphorus in Bulk and Tablet Dosage Form
Naresh Choudhary* , Parin Choksi, Rajashree Mashru
The Maharaja Sayajirao University of Baroda, G.H. Patel Pharmacy building, Donor’s Plaza, Fatehgunj, Vadodara 390001, Gujarat, India
|
Article Info: _____________________________________________ Article History: Received 14 April 2022 Reviewed 23 May 2022 Accepted 02 June 2022 Published 15 June 2022 _____________________________________________ Cite this article as: Choudhary N, Choksi P, Mashru R, New Smartphone based Colorimetric Method Development and validation for the Drugs containing Nitrogen, Sulphur and Phosphorus in Bulk and Tablet Dosage Form, Journal of Drug Delivery and Therapeutics. 2022; 12(3-S):87-100 DOI: http://dx.doi.org/10.22270/jddt.v12i3-s.5510 ____________________________________________ *Address for Correspondence: Naresh Choudhary, The Maharaja Sayajirao University of Baroda, G.H. Patel Pharmacy building, Donor’s Plaza, Fatehgunj, Vadodara 390001, Gujarat, India |
Abstract ___________________________________________________________________________________________________________________ A method for determining the concentration of coloured compounds in a solution is colorimetry. The intensity of the colour is related to the chemical concentration being measured. Because of their low cost and ability to collect, store, and interpret data all in one device, smartphone-based colorimetry has increased in popularity as an analytical tool. The camera on the phone is used as a detector in smartphone colorimetry. Both the smartphone colorimetric method and the UV method relied on the detection of colour intensity as concentration rose. Distinct oxidation states of ammonium metavanadate generate different colours depending on the oxidation state. The +5-oxidation state appears yellow, the +4-oxidation state appears blue, the +3-oxidation state appears green, and the +2-oxidation state appears purple. The ammonium metavanadate reagent is orange red in colour, but when it combines with pharmaceuticals that contain nitrogen, phosphorus, or sulphur in their structure, it turns green. The developed approach for all of the drugs in this article is linear. The colour intensity increases as the concentration of API increases. All of the photos were captured on a smartphone and analysed with photometrix PRO software. The photometrix PRO application turns an image to an RGB histogram, and it also includes regression models. The percent RSD for all three drugs was less than 2 employing Photometrix PRO and UV method. Using a statistical method called a two-paired test, the results reveal that both procedures are equally significant for all three drugs. Keywords: Uv spectrophotometry, Photometrix PRO, RGB Histogram, Sumatriptan Succinate, Gemifloxacin, Tenofovir disoproxil fumarate |
INTRODUCTION
Sumatriptan Succinate (Sulphur Atom):
Triptans are a class of tryptamine-based drugs intended to relieve migraine headaches in the short term. One of them, sumatriptan succinate, is structurally similar to the neurotransmitter serotonin. Sumatriptan succinate (STS) is a 5-hydroxytryptamine (5-HT) receptor subtype with a low affinity for 5-HT1A, 5-HT5A, and 5-HT7 receptors. Sumatriptan Succinate is chemically designed as [3-[2-(Dimethylamino) ethyl]-1H-indol-5-yl]-N-methyl methane-sulfonamide hydrogen butanedioate. 1–3
Figure 1: Structure of Sumatriptan Succinate4
Molecular weight: 413.5 g/mol
Molecular Formula: C14H21N3O2S.C4H6O4
Solubility: Freely Soluble in Water (0.127 mg/ml)
STS works by selectively binding to serotonin type-1D receptors (serotonin agonists) to end a migraine episode while also removing accompanying symptoms like nausea, vomiting, and light and sound sensitivity. Sumatriptan operates as a vasoconstrictor on a serotonin (5-HT)1B/1D receptor, which is also found in peripheral arteries to a lesser level. 6Sumatriptan also has a central inhibitory impact on the trigeminovascular system, which is engaged during migraine attacks. Triptans' potential mechanisms of action in migraine include cerebral vasoconstriction, decrease of neuropeptide and protein extravasation across dural arteries, and central inhibition of impulse transmission within the trigeminovascular system. 7,8Triptans' major function in migraine, in our opinion, is to constrict dilated cranial extracerebral blood arteries, which is a 5-HT1B impact. When pure 5-HT1D receptor agonists have been produced and tested for efficacy in migraine, the potential contribution of triptans' neuronal impact can be assessed. 4,8
Introduction to Gemifloxacin (Nitrogen Atom):
Gemifloxacin is a fourth generation, oral fluoroquinolones antibiotics used in the therapy of mild-to-moderate respiratory tract infections caused by susceptible organisms. Gemifloxacin is a 1,4-dihydro-1,8-napthyridine with a carboxy group at the 3-position, an oxo substituent at the 4-position, a fluoro substituent at the 5-position and substituted pyrrolin-1-yl group at the 7-position. It is monocarboxylic acid, a 1,8-napthyridine derivative, a quinolone antibiotic and a fluoroquinolone antibiotic. 9Like other fluoroquinolones, Gemifloxacin is active against a wide range of aerobic gram-positive and gram-negative organisms and is believed to act by inhibition of bacterial DNA gyrase and topoisomerase IV that are required for synthesis of bacterial mRNAs (transcription) and DNA replication. In contrast, DNA gyrase are not present in human cells and the equivalent topoisomerases are not sensitive to fluoroquinolone inhibition. Gemifloxacin was approved for use in the United States in 2003 and has not been as commonly used as other fluoroquinolones such as ciprofloxacin and levofloxacin.10,11
Figure 2: Structure of Gemifloxacin10
Molecular weight: 398.381 g/mol
Molecular Formula: C18H2OFN5O4
Solubility: Freely Soluble in neutral pH (350 mg/ml at 37°C, pH 7.0)
Current indications are limited to acute exacerbations of chronic bronchitis and community acquired pneumonia. Gemifloxacin is available under the commercial name Factive in 320 mg tablets. The recommended dose is 320 mg once daily for 5 to 7 days. Common side effects include diarrhoea, nausea, abdominal pain, headaches, skin rash and allergic reactions.10,11,13
Introduction to Tenofovir disoproxil fumarate (Phosphorus Atom):
Tenofovir disoproxil fumarate {9-[(R)-2-[[bis [[isopropoxycarbonyl] oxy] methoxy] phosphonyl] popyl] adenine fumarate} is a nucleotide analog reverse transcriptase inhibitor (NRTI) and is used for treating HIV infection in adults, in combination with other anti-retroviral agents. Due to the presence of a phosphonate group, tenofovir is negatively charged at neutral pH, which limits its oral bioavailability. During drug development, attention switched to the phosphonate ester derivative. Tenofovir disoproxil, which was the subject of extensive process chemistry to provide a viable manufacturing route. Tenofovir disoproxil, sold under the trade name Viread among others, is a medication used to treat chronic hepatitis B and to prevent and treat HIV/AIDS.14,15
Figure 3: Structure of Tenofovir Disoproxil Fumarate16
Molecular weight: 287.213 g/mol
Molecular Formula: C23H34N5O14P
Solubility: Freely Soluble in Dimethyl Sulfoxide and Water, sparingly soluble in methanol.
Tenofovir disoproxil is a nucleotide analog reverse-transcriptase inhibitor (NtRTI). It selectively inhibits viral reverse transcriptase, a crucial enzyme in retroviruses such as human immunodeficiency virus (HIV), while showing limited inhibition of human enzymes, such as DNA polymerases α, β, and mitochondrial DNA polymerase Ƴ. In vivo tenofovir disoproxil fumarate is converted to tenofovir, an acyclic analog of deoxyadenosine 5’ – monophosphate (dAMP). Tenofovir lacks a hydroxyl group in the corresponding to the 3’ carbon of the dAMP, preventing the formation of the 5’ to 3’ phosphodiester linkage essential for DNA chain elongation. Common side effects include nausea, rash, diarrhoea, headache, pain, depression, and weakness. Severe side effects include high blood lactate and an enlarged liver.17
Introduction to Colorimetric Analysis based on Smartphone Application
A light source, a monochromator, a photometer, an eyepiece for monitoring the photometric field, and a sample holder are the most common instruments used for work in the visual region. The holder is either a cell for measuring liquid transmission or a device for supporting a ran opaque object on which reflection measurements are to be taken. Unlike chemists' "colorimetric" conclusions, spectrophotometric measurements are not limited to coloured systems. Photographic methods were utilised for many years to determine absorption spectra in the ultraviolet and infrared regions of the spectrum.18,19
The fundamental data of a spectrophotometer indicates the proportion of incident light on a sample that is reflected or transmitted by it. A single value for a certain wavelength can be produced, or values for the complete visible range can be computed. In the latter cases, the findings are typically shown as a curve, with transmission or reflection as the ordinates and wavelength as the abscissas. 18The question of what wavelength interval to use to identify individual points and what spectral band width to utilise for the light source arises when building a curve that encompasses a portion or all of the visible range. If the slope is steep and features small sharp millimicrons with the narrowest spectral band possible.18
Colorimetric analysis is a useful technique for determining the concentration of a coloured material in a solution. Coloured compounds absorb visible light, and the amount of light absorbed is proportional to the concentration of the substance in solution.20 The light source in colorimetric chemistry analysers is a tungsten halogen bulb. The lamp must be modified with filters or a monochromator to get the desired wavelength.21
Color changes recorded with Smartphone-based sensors are gaining popularity in chemical research due to their ease of use and flexibility to portable equipment9. Smartphones have grown in popularity as analytical instruments due to their low cost and ability to collect, store, and process data all in one device. In smartphone colorimetry, the mobile camera serves as the detector.22
There are numerous smartphone-based colorimetric applications available. Photo Metric-PRO is one among them. Photo Metrix PRO could be downloaded for free from the Windows Phone Store and the Google Play Store. This programme uses simple linear correlation for univariate analysis and principal components analysis for multivariate exploratory analysis (PCA). The smartphone camera captures visual data, which is then translated into RGB histograms (red, green and blue).23–25
The RGB colour model is based on the colour perception theory, which states that the human eye has different sensitivity peaks located around red, green, and blue. Multivariate analysis could be employed in this software to increase the RGB colour system applicability of colorimetry.24
Colorimetry is a technique used in biological research to calculate the quantitative value of colours. Color is produced when a substance binds with color-forming chromogens. Differences in colour intensity resulted in variations in light absorption.20,26,27
The intensity of the colour is related to the concentration of the material being tested. The wavelength of visible light in the electromagnetic spectrum ranges from 400 nm to 800 nm. 27A colorimeter/visible spectrophotometer is a device that determines the concentration of a solution by measuring the absorbance of a specific wavelength of light. Consider the specificity and sensitivity of a reagent when selecting one for colorimetric analysis.25
The usage of advanced tools was required for this technique. The purpose of this research is to develop a simple, low-cost method for calculating Sumatriptan Succinate, Gemifloxacin and Tenofovir Disoproxil Fumarate. As a colouring component, ammonium metavanadate28–31 reacts with sumatriptan succinate, Gemifloxacin and Tenofovir Disoproxil Fumarate to generate green colour. The data image was acquired and analysed by the Photo Metrix-PRO application.
STS (Sumatriptan Succinate) has official monographs in BP (British Pharmacopoeia, 2009) and EP (European Pharmacopoeia, 2005), which describe liquid chromatographic methods for STS assay, as well as USP (The United States Pharmacopoeia, 2004), which describes a high-performance liquid chromatographic (HPLC) method for its determination.32,33 A review of the literature finds that few analytical methods, such as high-performance liquid chromatography (HPLC)24 and liquid chromatographic-mass spectrometry, have been reported for the analysis of STS in biological fluids.
EXPERIMENTAL:
5% Ammonium Metavanadate, Sumatriptan Succinate, Gemifloxacin, Tenofovir disoproxil fumarate, Double Distilled Water, 40% H₂SO₄.
The Sumatriptan Succinate, Gemifloxacin, and Tenofovir disoproxil fumarate API samples were weighed on an electronic balance (Ax120) (Shimadzu). Smartphone camera and uploaded to the mobile (Photometrix PRO) Application.
Weigh about 5gm of ammonium metavanadate reagent in 100ml of 40% H₂SO₄ and heat on water bath until solid residue dissolve.
Weigh about 10 mg of Sumatriptan Succinate, Gemifloxacin and Tenofovir disoproxil fumarate and transferred into a previously calibrated 10ml volumetric flask. The final volume was made up to the mark using double distilled to obtain the standard stock solution of 1000μg/ml concentration.
Method development:
Uv-Vis Spectroscopy:
Selection of wavelength for Sumatriptan Succinate, Gemifloxacin and Tenofovir Disoproxil Fumarate:
Using Ammonium Metavanadate as a blank, the drug solution was scanned across the range 400-800 nm. Sumatriptan Succinate, Gemifloxacin and Tenofovir disoproxil fumarate was found to have an absorbance of 762 nm. Prepare a calibration curve using the working solution, ranging from 50-250 μg/ml for Sumatriptan Succinate and Gemifloxacin while 30-120 μg/ml and construct a linear regression equation.
Reaction Mechanism:
Ammonium metavanadate is inorganic oxidizing agent. The vanadate has oxidation states in its compound of +5, +4, +3 and +2. The usual source of vanadium in the +5-oxidation state in ammonium metavanadate. The reaction for oxidation of sumatriptan was done in acidic medium. Heat is given during chemical reaction to prevent reoxidation. Ammonium metavanadate is orange red color complex but when it reacting with sumatriptan succinate, Gemifloxacin and Tenofovir disoproxil fumarate it forms green colour complex
|
SO₃H |
|
NH |
|
N |
|
CH₃NH₃ |
Oxidation state: From +5 it comes to +3 of vanadium.
Method Optimization:
Optimization of reagent concentration:
Ammonium metavanadate was allowed to react with sumatriptan succinate to form a green colour with absorption maxima at 762 nm, by keeping another parameter constant. The optimization of the experiment was established by varying the concentration of reagent in the range of 2.5% - 20%, where, maximum absorbance of reagent was found at 5% as shown in Table 1.
Table 1: Optimization of reagent concentration
|
Sr.No. |
Concentration |
Observation |
|
1 |
2.5% |
No stable colour changes. |
|
2 |
5% |
Stable colour changes. |
|
3 |
10% |
No Stable colour changes. |
|
4 |
15% |
Reagent got Saturated (Dark red colour) |
|
5 |
20% |
Reagent doesn’t dissolve. |
Optimization of reagent volume for Sumatriptan Succinate:
The effect of reagent volume was studied in a range of 1 to 6 millilitres. The volume was tuned based on the green colour complex and the absorbance maxima. The absorbance increases with increasing reagent volume until 4ml, after which it decreases, hence 4ml was chosen for the procedure as shown in Table 2.
Table2: Optimization of reagent volume for Sumatriptan Succinate
|
Percent of Reagent (%) |
Absorbance (nm) |
|
1% |
0.090 nm |
|
2% |
0.117 nm |
|
3% |
0.153nm |
|
4% |
0.341nm |
|
5% |
0.207nm |
|
6% |
0. 132nm |
Optimization of reagent volume for Gemifloxacin:
The influence of reagent volume was investigated in a range of 1 to 6 mL. The optimal volume was chosen observing the green colour complex and absorbance maxima. As the volume of reagent was increased up to 4ml, the absorbance fell, so 4ml of reagent was chosen for the procedure as indicated in Table 3.
Table 3: Optimization of reagent volume for Gemifloxacin
|
Percent of Reagent (%) |
Absorbance (nm) |
|
1% |
0.113 |
|
2% |
0.153 |
|
3% |
0.201 |
|
4% |
0.240 |
|
5% |
0.234 |
|
6% |
0.229 |
Optimization of regent volume for Tenofovir Disoproxil Fumarate:
In a range of 1 to 6 mL, the effect of reagent volume was examined. The green colour complex and absorbance maxima were used to determine the appropriate volume. The absorbance decreased when the reagent volume was raised up to 4ml, hence 4ml of reagent was chosen for the experiment as shown in Table 4.
Table 4: Optimization of reagent volume for Tenofovir Disoproxil Fumarate
|
Percent of Reagent (%) |
Absorbance (nm) |
|
1% |
0.112 |
|
2% |
0.135 |
|
3% |
0.152 |
|
4% |
0.179 |
|
5% |
0.169 |
|
6% |
0.161 |
Optimization of reaction time for Sumatriptan Succinate:
The influence of reaction time was studied for 10 to 50 minutes. Between 10 and 50 minutes was recorded for the colour complex reaction. At 30 minutes, there was a little increase in colour intensity.
Figure 4: Optimization of reaction time for Sumatriptan Succinate
Optimization of reaction time for Gemifloxacin:
The influence of reaction time was studied for 10 to 50 minutes. Between 10 and 50 minutes was recorded for the colour complex reaction. At 30 minutes, there was a little increase in colour intensity.
Figure 5: Optimization of reaction time for Gemifloxacin
Optimization of reaction time for Tenofovir Disoproxil Fumarate:
The influence of reaction time was studied for 10 to 50 minutes. Between 10 and 50 minutes was recorded for the colour complex reaction. At 30 minutes, there was a little increase in colour intensity.
Figure 6: Optimization of reaction time for Tenofovir Disoproxil Fumarate
Preparation of Calibration graph for Sumatriptan Succinate, Gemifloxacin and Tenofovir Disoproxil Fumarate:
Estimation of Sumatriptan Succinate Using Smartphone Application:
Experimental Setup:
As indicated in Figure 8, the coloured solution was transferred into a slandered glass cuvette that was put in an 18cm x 18cm white box with a 6W LED (Light Emitting Diode) bulb to adjust the intensity during the experiment.
Figure 7: Experimental Set up
A smartphone image of a colour complex solution was obtained and analysed using a photometric tool to calculate the image's red-green-blue intensities (RGB scale). A linear regression equation was used to estimate the concentration of the image captured by Photometrix PRO. Photometrix generates and analyses RGB colour histograms before converting them to a calibration curve. This programme processes and shows the findings using univariate and multivariate analysis. Many different smartphone kinds were employed to achieve the best results. The methods for using the Photometrix application are shown in Figure 9.
Figure 8: Steps for run the photometrix pro application
Method Validation:
According to validation requirements, the UV-visible spectrophotometry and Photometrix applications were separately validated in terms of linearity and robustness. For both approaches, a formulation assay was carried out. Under optimal conditions, excellent linearity was reported in the range of 50-250 μg/ml. In the case of UV-Vis spectrophotometry, the concentration of tablet formulation was calculated using a regression equation, while Photometrix was calculated within the programme.
RESULT AND DISCUSSION:
Method Validation34:
The UV-visible spectrophotometry and PhotoMetrix applications were validated individually in terms of linearity and robustness, according to validation requirements. A formulation assay was performed for both techniques. Excellent linearity Sumatriptan Succinate and Gemifloxacin was recorded in the range of 50-250 μg/ml under ideal conditions, while Tenofovir Disoproxil Fumarate was reported in the range of 30-150 μg/ml. The concentration of tablet formulation was determined using a regression equation in UV-vis spectrophotometry, whereas photometrix was calculated within the programme.
1. Linearity:
By following Beer's law, Sumatriptan Succinate and Gemifloxacin were linear with concentrations ranging from 50 to 250 μg/ml at 762 nm, while Tenofovir disoproxil fumarate was linear with concentrations ranging from 30-150 μg/ml at 762 nm (Figure 10). Between concentration and absorbance, a calibration curve was produced. It was discovered that the plot was linear (Figure 11).
Figure 9: Linearity of Sumatriptan Succinate (A), Gemifloxacin (B), Tenofovir Disoproxil Fumarate (C)
Figure 10: Calibration graph for Sumatriptan Succinate, Gemifloxacin, Tenofovir Disoproxil Fumarate
2. Precision:
The degree of agreement between a set of measurements obtained by sampling the same homogenous sample numerous times under the method's defined circumstances is referred to as the precision of an analytical method. Here, we calculated the intraday (Repeatability) and interday precision. Three-concentration samples of both drugs' lowest, upper, and middle limits were taken and analysed three times on the same day for intra-day precision and three times on three different days for inter-day precision. It was established that the % RSD was less than 2.
Table 5: Interday and Intraday Precision data for Sumatriptan Succinate
|
Conc. (μg/ml) |
Set 1 |
Set 2 |
Set 3 |
Mean ± SD |
%RSD |
|
|
Intra Day |
50 (μg/ml) |
0.075 |
0.076 |
0.074 |
0.075 ± 0.001 |
1.33% |
|
100 (μg/ml) |
0.141 |
0.142 |
0.140 |
0.141 ± 0.0009 |
0.71% |
|
|
150 (μg/ml) |
0.206 |
0.206 |
0.208 |
0.206 ± 0.0011 |
0.56% |
|
|
200 (μg/ml) |
0.275 |
0.276 |
0.277 |
0.276 ± 0.0008 |
0.36% |
|
|
250 (μg/ml) |
0.332 |
0.334 |
0.337 |
0.334 ± 0.002 |
0.75% |
|
|
Inter Day |
50 (μg/ml) |
0.075 |
0.073 |
0.074 |
0.074 ± 0.001 |
1.35% |
|
100 (μg/ml) |
0.141 |
0.144 |
0.145 |
0.143 ± 0.002 |
1.45% |
|
|
150 (μg/ml) |
0.206 |
0.207 |
0.204 |
0.205 ± 0.001 |
0.74% |
|
|
200 (μg/ml) |
0.276 |
0.279 |
0.277 |
0.277 ± 0.001 |
0.55% |
|
|
250 (μg/ml) |
0.341 |
0.337 |
0.332 |
0.336 ± 0.003 |
1.34% |
Table 6: Interday and Intraday Precision data for Gemifloxacin
|
Conc. (μg/ml) |
Set 1 |
Set 2 |
Set 3 |
Mean ± SD |
%RSD |
|
|
Intra Day |
50 (μg/ml) |
0.108 |
0.109 |
0.111 |
0.109 ± 0.001 |
1.40% |
|
100 (μg/ml) |
0.212 |
0.215 |
0.217 |
0.214 ± 0.002 |
1.17% |
|
|
150 (μg/ml) |
0.316 |
0.314 |
0.316 |
0.315 ± 0.0009 |
0.37% |
|
|
200 (μg/ml) |
0.403 |
0.415 |
0.417 |
0.411 ± 0.006 |
1.84% |
|
|
250 (μg/ml) |
0.510 |
0.516 |
0.507 |
0.511 ± 0.004 |
0.90% |
|
|
Inter Day |
50 (μg/ml) |
0.108 |
0.110 |
0.111 |
0.109 ± 0.002 |
1.39% |
|
100 (μg/ml) |
0.212 |
0.217 |
0.212 |
0.213 ± 0.002 |
1.35% |
|
|
150 (μg/ml) |
0.316 |
0.319 |
0.319 |
0.318 ± 0.001 |
0.54% |
|
|
200 (μg/ml) |
0.413 |
0.417 |
0.420 |
0.416 ± 0.007 |
0.84% |
|
|
250 (μg/ml) |
0.510 |
0.511 |
0.513 |
0.511 ± 0.001 |
0.30% |
Intraday precision and Interday precision data of Tenofovir Disoproxil Fumarate
Table 71: Interday and Intraday Precision data for Tenofovir Disoproxil Fumarate
|
Conc. (μg/ml) |
Set 1 |
Set 2 |
Set 3 |
Mean ± SD |
%RSD |
|
|
Intra Day |
30 (μg/ml) |
0.037 |
0.038 |
0.037 |
0.037 ± 0.0005 |
1.55% |
|
60 (μg/ml) |
0.075 |
0.077 |
0.076 |
0.076 ± 0.001 |
1.32% |
|
|
90 (μg/ml) |
0.109 |
0.113 |
0.110 |
0.110 ± 0.002 |
1.88% |
|
|
120 (μg/ml) |
0.147 |
0.144 |
0.145 |
0.145 ± 0.001 |
1.05% |
|
|
150 (μg/ml) |
0.177 |
0.180 |
0.178 |
0.178 ± 0.001 |
0.86% |
|
|
Inter Day
|
30 (μg/ml) |
0.037 |
0.036 |
0.037 |
0.036 ± 0.005 |
1.57% |
|
60 (μg/ml) |
0.075 |
0.077 |
0.076 |
0.076 ± 0.001 |
1.32% |
|
|
90 (μg/ml) |
0.112 |
0.114 |
0.113 |
0.113 ± 0.001 |
0.88% |
|
|
120 (μg/ml) |
0.145 |
0.142 |
0.147 |
0.144 ± 0.002 |
1.74% |
|
|
150 (μg/ml) |
0.177 |
0.181 |
0.179 |
0.179 ± 0.002 |
1.12% |
3) Accuracy:
The Accuracy of the method was determined by recovery experiments. A known quantity of the pure drug was added to the pre-analysed sample formulation at 80%, 100% and 120% levels. The recovery studies were carried out and percentage recovery and percentage relative standard deviation of the percentage recovery were calculated and given in Table: 8.
Table 8: Accuracy data for formulation of Sumatriptan Succinate (Tablet)
|
Drug |
Standard Concentration (μg/ml) |
% Spiked |
Conc. Added From formulation (n=3) (μg/ml) |
Conc. Recoverd (n=3) |
%recovery ± SD (n=3) |
%RSD |
|
Sumatriptan Succinate |
100 (μg/ml) |
80% |
80 (μg/ml) |
179.58 |
99.72 ± 0.5 |
0.40% |
|
100 (μg/ml) |
100% |
100 (μg/ml) |
199.73 |
99.86 ± 0.3 |
0.96% |
|
|
100 (μg/ml) |
120% |
120 (μg/ml) |
222.31 |
101.04 ± 0.8 |
1.02% |
Table 92: Accuracy data for Gemifloxacin Tablet Formulation
|
Drug |
Standard Concentration (μg/ml) |
% Spiked |
Conc. Added From formulation (n=3) (μg/ml) |
Conc. Recoverd (n=3) |
%recovery ± SD (n=3) |
%RSD |
|
Gemifloxacin |
100 (μg/ml) |
80% |
80 (μg/ml) |
179.85 |
99.44 ± 0.2 |
0.14% |
|
100 (μg/ml) |
100% |
100 (μg/ml) |
199.85 |
99.92 ± 0.7 |
0.36% |
|
|
100 (μg/ml) |
120% |
120 (μg/ml) |
220.35 |
100.15 ± 0.8 |
0.37% |
Table10: Accuracy data for Tenofovir Disoproxil Fumarate
|
Drug |
Standard Concentration (μg/ml) |
% Spiked |
Conc. Added From formulation (n=3) (μg/ml) |
Conc. Recoverd (n=3) |
%recovery ± SD (n=3) |
%RSD |
|
Gemifloxacin |
60 (μg/ml) |
80% |
80 (μg/ml) |
107.86 |
99.81 ± 0.4 |
0.41% |
|
60 (μg/ml) |
100% |
100 (μg/ml) |
119.56 |
99.58 ± 0.3 |
0.28% |
|
|
60 (μg/ml) |
120% |
120 (μg/ml) |
130.27 |
98.63 ± 0.9 |
0.93 % |
4) Specificity:
The blank and marketed formulations with excipients were used to determine specificity, and a 100 μg/ml solution was generated from the marketed formulation. The specificity of the approach is proven in the graph below, which displays the specific absorbance of sumatriptan succinate at 762 nm. As a result, we can conclude that this strategy is unique.
Figure 11: Specificity indicating graph of Sumatriptan Succinate (a), Gemifloxacin (b), Tenofovir Disoproxil Fumarate (c)
5) Ruggedness of method:
The developed method's robustness was investigated in two labs and with two distinct cellphones. As indicated in Table 11, the percent RSD for both of these parameters is less than 2 (Sumatriptan Succinate) Table 12 (Gemilfoxacin) Table 13 (Tenofovir disoproxil fumarate)
Table 11: Ruggedness data for Sumatriptan Succinate
|
Parameter |
Mean assay% |
SD |
%RSD |
|
Lab 1 |
99.98 |
0.06 |
0.07% |
|
Lab 2 |
100.02 |
||
|
Smartphone 1 |
100.16 |
0.04 |
0.05% |
|
Smartphone 2 |
100.19 |
Table 12: Ruggedness data for Gemifloxacin
|
Parameter |
Mean assay% |
SD |
%RSD |
|
Lab 1 |
99.65 |
0.02 |
0.03% |
|
Lab 2 |
101.23 |
||
|
Smartphone 1 |
100.63 |
0.03 |
0.03% |
|
Smartphone 2 |
99.52 |
Table 13: Ruggedness data for Tenofovir Disoproxil Fumarate
|
Parameter |
Mean assay% |
SD |
%RSD |
|
Lab 1 |
99.96 |
0.09 |
0.10% |
|
Lab 2 |
100.89 |
||
|
Smartphone 1 |
101.45 |
0.03 |
0.04% |
|
Smartphone 2 |
99.86 |
Estimation of Sumatriptan Succinate using Smartphone application:
The image was obtained using the PhotoMetrix PRO application and sorted by concentration, revealing colour gradients for all three drugs (Figure 13). It was discovered the linear regression equation (Figure 14). Table 17 shows the regression equation data for both methods for all three drugs.
Figure 12: Chart of colour intensity corresponding to the concentration of Sumatriptan Succinate(A), Gemifloxacin (B) and Tenofovir Disoproxil Fumarate(C)
Figure 13: Calibration curve of the Sumatriptan Succinate (A), Gemifloxacin (B) and Tenofovir disoproxil fumarate(C) by Photometrix pro application
Table 143: Regression data for both UV and Photometrix application
|
Parameter |
Drugs |
UV Method |
Photometric application |
|
Linearity (μg/ml) |
Sumatriptan Succinate |
50-250 |
50-250 |
|
|
Gemifloxacin |
50-250 |
50-250 |
|
|
Tenofovir Disoproxil Fumarate |
30-150 |
30-150 |
|
Regression equation |
Sumatriptan Succinate |
Y= 0.0013x + 0.0113 |
Y = 0.360x + 7.747 |
|
|
Gemifloxacin |
Y= 0.002x + 0.0141 |
Y = 0.443x – 2.258 |
|
|
Tenofovir Disoproxil Fumarate |
Y=0.0012x + 0.0036 |
Y = 1.108x + 0.476 |
|
Slope |
Sumatriptan Succinate |
0.0013 |
0.360 |
|
|
Gemifloxacin |
0.002 |
0.443 |
|
|
Tenofovir Disoproxil Fumarate |
0.0012 |
1.108 |
|
Intercept |
Sumatriptan Succinate |
0.0113 |
7.747 |
|
|
Gemifloxacin |
0.0141 |
2.258 |
|
|
Tenofovir Disoproxil Fumarate |
0.0036 |
0.476 |
|
Correlation Coefficient |
Sumatriptan Succinate |
0.999 |
0.987 |
|
|
Gemifloxacin |
0.999 |
0.999 |
|
|
Tenofovir Disoproxil Fumarate |
0.999 |
0.999 |
|
LOD (μg/ml) |
Sumatriptan Succinate |
3.5 |
4.99 |
|
|
Gemifloxacin |
8.25 |
9.65 |
|
|
Tenofovir Disoproxil Fumarate |
2.75 |
3.45 |
|
LOQ (μg/ml) |
Sumatriptan Succinate |
11 |
15.12 |
|
|
Gemifloxacin |
25 |
28.95 |
|
|
Tenofovir Disoproxil Fumarate |
8.26 |
10.35 |
The linearity of Sumatriptan succinate and Gemifloxacin was measured between 50 and 250 g/ml, while Tenofovir Disoproxil Fumarate was measured between 30 and 150 g/ml. Figure 11 depicts the calibration curve and regression equation obtained by the application.
Assay of formulation:
Both methodologies were used to perform the analysis on the marketed formulation. The concentration of sample solutions was approximated as a percent Recovery from a linear regression equation. For both approaches, the assay findings were found to be within an acceptable range and significant. Table 15 shows the results of the assays.
Table15: Assay results of different formulation for both the methods
|
|
|
UV |
Photometrix |
||||||
|
Drugs |
Formulations |
Amount taken (μg/ml) |
Amount recovered (μg/ml) |
% Recovery |
%RSD |
Amount taken (μg/ml) |
Amount recovered(μg/ml) |
%Recovery |
%RSD |
|
Sumatriptan |
1 |
100 |
99.82 |
99.82 |
0.14% |
100 |
99.35 |
99.35 |
0.11% |
|
2 |
100 |
99.10 |
99.10 |
0.23% |
100 |
98.65 |
98.65 |
0.19% |
|
|
3 |
100 |
100.1 |
100.1 |
0.36% |
100 |
99.56 |
99.56 |
0.65% |
|
|
Gemifloxacin |
1 |
100 |
99.73 |
99.73 |
0.08% |
100 |
99.16 |
99.16 |
0.37% |
|
2 |
100 |
99.85 |
99.85 |
0.06% |
100 |
99.35 |
99.35 |
0.33% |
|
|
3 |
100 |
99.63 |
99.63 |
0.13% |
100 |
99.22 |
99.22 |
0.11% |
|
|
Tenofovir disoproxil Fumarate |
1 |
60 |
59.56 |
99.26 |
0.30% |
60 |
59.76 |
99.60 |
0.35% |
|
2 |
60 |
59.39 |
98.98 |
0.18% |
60 |
59.63 |
99.38 |
0.10% |
|
|
3 |
60 |
59.84 |
99.73 |
0.19% |
60 |
59.71 |
99.51 |
0.13% |
|
Statistical Comparison of two methods:
To compare the results of the Photometrix application with the UV technique, a paired t-test was performed (two tails). T-stat values were found to be lower than t-critical values, and P values were greater than the applied alpha value (*P>0.05) using a t-test. It means that the procedures have no discernible differences. As a result, the Photometrix programme can estimate Sumatriptan succinate, Gemifloxacin, and Tenofovir Disoproxil Fumarate colorimetrically. The information is presented in Table 16.
Table 164: Applied Pair t-Test Result
|
Parameters |
Drugs |
Uv Method |
Photometrix PRO |
|
Mean (X) |
Sumatriptan Succinate |
100.046 |
100.152 |
|
|
Gemifloxacin |
99.792 |
99.376 |
|
|
Tenofovir Disoproxil Fumarate |
59.642 |
59.776 |
|
Variance (S²) |
Sumatriptan Succinate |
0.10333 |
0.15052 |
|
|
Gemifloxacin |
0.01392 |
0.05483 |
|
|
Tenofovir Disoproxil Fumarate |
0.03287 |
0.01318 |
|
Observation (n) |
Sumatriptan Succinate |
5 |
5 |
|
|
Gemifloxacin |
5 |
5 |
|
|
Tenofovir Disoproxil Fumarate |
5 |
5 |
|
Pearson Correlation |
Sumatriptan Succinate |
0.157242 |
|
|
|
Gemifloxacin |
0.852799 |
|
|
|
Tenofovir Disoproxil Fumarate |
0.525365 |
|
|
Hypothesized mean difference |
Sumatriptan Succinate |
0 |
|
|
|
Gemifloxacin |
0 |
|
|
|
Tenofovir Disoproxil Fumarate |
0 |
|
|
Df |
Sumatriptan Succinate |
8 |
|
|
|
Gemifloxacin |
6 |
|
|
|
Tenofovir Disoproxil Fumarate |
7 |
|
|
t stat |
Sumatriptan Succinate |
-0.470437879 |
|
|
|
Gemifloxacin |
3.54766 |
|
|
|
Tenofovir Disoproxil Fumarate |
-1.39629 |
|
|
P (T<=t) one-tail |
Sumatriptan Succinate |
0.325300597 |
|
|
|
Gemifloxacin |
0.006053 |
|
|
|
Tenofovir Disoproxil Fumarate |
0.102654 |
|
|
T Critical one-tail |
Sumatriptan Succinate |
1.859548038 |
|
|
|
Gemifloxacin |
1.94318 |
|
|
|
Tenofovir Disoproxil Fumarate |
1.894579 |
|
|
P (T<=t) two-tail |
Sumatriptan Succinate |
0.650601194 |
|
|
|
Gemifloxacin |
0.012106 |
|
|
|
Tenofovir Disoproxil Fumarate |
0.205308 |
|
|
T Critical two tail |
Sumatriptan Succinate |
2.306004135 |
|
|
|
Gemifloxacin |
2.446912 |
|
|
|
Tenofovir Disoproxil Fumarate |
2.364624 |
|
CONCLUSION:
Ammonium metavanadate is an oxidising agent that changes oxidation states from +5 to +3. We're using its oxidation power as a colorimetric reagent to show the importance of colour change in the presence of an acidic medium and heat when reacting with compounds that include sulphur, nitrogen, and phosphorus atoms. For Sumatriptan Succinate, Gemifloxacin, and Tenofovir disoproxil fumarate, the smartphone-based PhotoMetrix PRO software is being used to develop a new and cost-effective colorimetric detection approach. The technique was based on a simple colourant and a quick procedure. The main purpose of this project was to use smartphone-based applications to make colorimetric drug content measurement easier. The approach was also compared to a UV method created using the same reagent and technology, and there were no statistically significant differences in assay findings. In quantitative drug estimation in pharmaceutical dose forms, this revolutionary method can be employed as an alternative to analytical science.
REFERENCES:
1. Rawat, K. A., Surati, K. R., & Kailasa, S. K. (2014). One-pot synthesis of gold nanoparticles by using 4-aminoantipyrine as a novel reducing and capping agent for simultaneous colorimetric sensing of four triptan-family drugs. Anal. Methods, 6(15), 5972–5980. https://doi.org/10.1039/C4AY00098F
2. ALTRIA, K. D. F. S. D. (n.d.). Quantitative determination of Sumatriptan by capillary electrophoresis. Pascal and Francis Bibliographic Databases.
3. Bebawy, L. I., Moustafa, A. A., & Abo-Talib, N. F. (2003). Stability-indicating methods for the determination of sumatriptan succinate. Journal of Pharmaceutical and Biomedical Analysis, 32(6), 1123–1133. https://doi.org/10.1016/S0731-7085(03)00245-0
4. K N, P. K., Kanakapura, B., & Raghu, M. S. (2013). Permaganometric determination of sumatriptan succinate in pure drug and pharmaceutical formulation. Thai Journal of Pharmaceutical Sciences, 37, 95–106.
5. Wishart, D. S., Feunang, Y. D., Guo, A. C., Lo, E. J., Marcu, A., Grant, J. R., Sajed, T., Johnson, D., Li, C., Sayeeda, Z., Assempour, N., Iynkkaran, I., Liu, Y., Maciejewski, A., Gale, N., Wilson, A., Chin, L., Cummings, R., Le, D., … Wilson, M. (2018). DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Research, 46(D1), D1074–D1082. https://doi.org/10.1093/nar/gkx1037
6. Andrew, P. D., Birch, H. L., & Phillpot, D. A. (1993). Determination of sumatriptan succinate in plasma and urine by high-performance liquid chromatography with electrochemical detection. Journal of Pharmaceutical Sciences, 82(1), 73–76. https://doi.org/10.1002/jps.2600820116
7. Prashanth, K. N., Basavaiah, K., & Raghu, M. S. (2013). Utilization of N -Bromosuccinimide as a Brominating Agent for the Determination of Sumatriptan Succinate in Bulk Drug and Tablets. International Journal of Analytical Chemistry, 2013, 1–11. https://doi.org/10.1155/2013/934357
8. Prashanth, K. N., Basavaiah, K., & Xavier, C. M. (2014). Development and validation of UV-spectrophotometric methods for the determination of sumatriptan succinate in bulk and pharmaceutical dosage form and its degradation behavior under varied stress conditions. Journal of the Association of Arab Universities for Basic and Applied Sciences, 15(1), 43–52. https://doi.org/10.1016/j.jaubas.2013.03.004
9. Paim, C. S., Führ, F., Miron, D. S., Steppe, M., & Schapoval, E. E. S. (2014). Highly Selective Colorimetric Method to Determine Gemifloxacin Mesylate in the Presence of a Synthetic Impurity. Journal of AOAC INTERNATIONAL, 97(1), 94–98. https://doi.org/10.5740/jaoacint.10-428
10. Mohammad, Y., Kumar, B. P., Hussain, A., & Harish. (2010). Development and Validation of RP-HPLC Method for the Estimation of Gemifloxacin Mesylate in Bulk and Pharmaceutical Dosage Forms. E-Journal of Chemistry, 7(4), 1621–1627. https://doi.org/10.1155/2010/824210
11. Vijayakumar, B., Seethamma, M., & Venkateshwarlu, G. (2016). Spectrophotometric Determination Of Drugs Based On Oxidation By Using Bromate-Bromide Mixture And Methyl Orange Dye.
12. Wishart, D. S., Knox, C., Guo, A. C., Cheng, D., Shrivastava, S., Tzur, D., Gautam, B., & Hassanali, M. (2008). DrugBank: a knowledgebase for drugs, drug actions and drug targets. Nucleic Acids Research, 36(suppl_1), D901–D906. https://doi.org/10.1093/nar/gkm958
13. Sasikala, M., & Tirupati, B. (2015). Spectrophotometric determination of drugs by using Cerium (IV) and Rhodamine B couple as analytical reagent.
14. Varsha, M. S., Babu, N. R., Padmavathi, Y., & Kumar, P. R. (2015). Development of new spectrophotometric method for estimation of tenofovir disoproxil fumarate using MBTH reagent. International Current Pharmaceutical Journal, 4(4), 378–381. https://doi.org/10.3329/icpj.v4i4.22620
15. AbdelHay, M. H., Gazy, A. A., Shaalan, R. A., & Ashour, H. K. (2013). Simple Spectrophotometric Methods for Determination of Tenofovir Fumarate and Emtricitabine in Bulk Powder and in Tablets. Journal of Spectroscopy, 2013, 1–7. https://doi.org/10.1155/2013/937409
16. M, L. M., & N., K. R. (2019). A REVIEW ON ANALYTICAL METHODS FOR ESTIMATION OF TENOFOVIR DISOPROXIL FUMARATE AND EMTRICITABINE IN BULK AND PHARMACEUTICAL DOSAGE FORMS. International Journal of Pharmaceutical and Biological Science Archive, 7(3). https://doi.org/10.32553/ijpba.v7i3.129
17. Jadhav Swapnil .D, Sarak Sharad .C, Nimbalkar Tushar .S, & Bhatia Manish .S. (2014). Designing of Colorimetric Reagent and Development of Stability Indicating Method for Analysis of Drugs with Fumarate Salt. Asian Journal of Pharmaceutical Analysis, 31–35.
18. Ramu, B. K., & Raghubabu, K. (2011). A simple colorimetric determination of sumatriptan succinate from tablet dosage forms using cobalt thio cyanate. International Journal of Pharmacy and Technology, 3, 1411–1418.
19. Kalyanaramu, B., & Raghubabu, K. (2011). A simple visible spectrophotometric determination of Sumatriptan Succinate from pharmaceutical formulations. Der Pharma Chemica, 3.
20. JOHNSTON, R. M. (1972). What is Color? (pp. 4–16). https://doi.org/10.1021/ba-1971-0107.ch002
21. SOWJANYA, G., & Kommoju, M. (2019). Colorimetric Approaches To Drug Analysis And Applications -A Review. American Journal of PharmTech Research, 9, 14–37. https://doi.org/10.46624/ajptr.2019.v9.i1.002
22. Kap, Ö., Kılıç, V., Hardy, J. G., & Horzum, N. (2021). Smartphone-based colorimetric detection systems for glucose monitoring in the diagnosis and management of diabetes. The Analyst, 146(9), 2784–2806. https://doi.org/10.1039/D0AN02031A
23. Alawsi, T., Mattia, G. P., Al-Bawi, Z., & Beraldi, R. (2021). Smartphone-based colorimetric sensor application for measuring biochemical material concentration. Sensing and Bio-Sensing Research, 32, 100404. https://doi.org/10.1016/j.sbsr.2021.100404
24. Sajed, S., Kolahdouz, M., Sadeghi, M. A., & Razavi, S. F. (2020). High-Performance Estimation of Lead Ion Concentration Using Smartphone-Based Colorimetric Analysis and a Machine Learning Approach. ACS Omega, 5(42), 27675–27684. https://doi.org/10.1021/acsomega.0c04255
25. Kılıç, V., Alankus, G., Horzum, N., Mutlu, A. Y., Bayram, A., & Solmaz, M. E. (2018). Single-Image-Referenced Colorimetric Water Quality Detection Using a Smartphone. ACS Omega, 3(5), 5531–5536. https://doi.org/10.1021/acsomega.8b00625
26. Shen, L., Hagen, J. A., & Papautsky, I. (2012). Point-of-care colorimetric detection with a smartphone. Lab on a Chip, 12(21), 4240. https://doi.org/10.1039/c2lc40741h
27. Stockman, A. (2004). Colorimetry. In digital Encyclopedia of Applied Physics. Wiley-VCH Verlag GmbH & Co. KGaA. https://doi.org/10.1002/3527600434.eap624
28. Sonar, S. S., Kategaonkar, A. H., Ware, M. N., Gill, C. H., Shingate, B. B., & Shingare, M. S. (2009). Ammonium metavanadate: an effective catalyst for synthesis of α-hydroxyphosphonates. Arkivoc, 2009(2), 138–148. https://doi.org/10.3998/ark.5550190.0010.215
29. Sadaphal, S., Kategaonkar, A., Sapkal, S., Shingate, B., Gill, C., & Shingare, M. (2009). Ammonium metavanadate: A novel catalyst for synthesis of α-aminophosphonates. Bulletin of Catalysis Society of India, 8, 131–139.
30. Jadhav, G. R., Shaikh, M. U., Kale, R. P., & Gill, C. H. (2009). Ammonium metavanadate: A novel catalyst for synthesis of 2-substituted benzimidazole derivatives. Chinese Chemical Letters, 20(3), 292–295. https://doi.org/10.1016/j.cclet.2008.09.057
31. Cavell, A. J. (1955). The colorimetric determination of phosphorus in plant materials. Journal of the Science of Food and Agriculture, 6(8), 479–480. https://doi.org/10.1002/jsfa.2740060814
32. Ravi, S., Darwis, Y., & Khan, N. (2009). Development and validation of an RP-HPLC-UV method for analysis of sumatriptan succinate in pharmaceutical dosage forms. Acta Chromatographica, 21(3), 421–432. https://doi.org/10.1556/AChrom.21.2009.3.6
33. Pourmand, M. R., Azar, M. S., & Aghavalijamaat, M. (2011). Development of validated UV spectrophotometric method for in vitro analysis of sumatriptan in pharmaceutical preparations in comparison with HPLC. Pharmaceutical Chemistry Journal, 44(10), 585–589. https://doi.org/10.1007/s11094-011-0522-1
34. Borman, P., & Elder, D. (2017). Q2(R1) Validation of Analytical Procedures: An Implementation Guide (pp. 127–166). https://doi.org/10.1002/9781118971147.ch5